Literature DB >> 16614605

Treatment of central pontine myelinolysis with thyrotropin-releasing hormone.

Emile F Zein1, Souheil E Karaa, Florence Rollot, Philippe Blanche, Raymond E Chemaly.   

Abstract

INTRODUCTION: Central pontine myelinolysis (CPM), demyelination of the brain stem, is a brain injury apparently due to osmotic forces. There is no consensus for its treatment. CASE: We describe here a case of CPM that occurred in a young patient after correction of hyponatremia, its treatment by intravenous thyrotropin-releasing hormone, and its outcome. DISCUSSION: Although very few instances of thyrotropin-releasing hormone treatment for CPM have been described, it appears to be effective and well tolerated. Studies are needed to assess its real efficacy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614605     DOI: 10.1016/s0755-4982(06)74651-6

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

1.  Osmotic demyelination syndrome as the initial manifestation of a hyperosmolar hyperglycemic state.

Authors:  Karla Victoria Rodríguez-Velver; Analy J Soto-Garcia; María Azucena Zapata-Rivera; Juan Montes-Villarreal; Jesús Zacarías Villarreal-Pérez; René Rodríguez-Gutiérrez
Journal:  Case Rep Neurol Med       Date:  2014-11-09

Review 2.  Osmotic Demyelination: From an Oligodendrocyte to an Astrocyte Perspective.

Authors:  Charles Nicaise; Catherine Marneffe; Joanna Bouchat; Jacques Gilloteaux
Journal:  Int J Mol Sci       Date:  2019-03-05       Impact factor: 5.923

3.  Prolonged Altered Mental Status in a Diabetic Hemodialysis Patient.

Authors:  Mojgan Jalalzadeh; Ashok Chaudhari; Donald Baumstein
Journal:  Cureus       Date:  2021-02-04

4.  Alcoholic pontine myelinolysis: beware the stroke mimic.

Authors:  Kieran Kusel; Omar Azzam; Adam Youssef; David Prentice
Journal:  BJR Case Rep       Date:  2021-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.